IRIS
SINAGRA, GIANFRANCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.561
AS - Asia 3.190
EU - Europa 2.342
SA - Sud America 667
AF - Africa 97
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 1
Totale 10.866
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.350
SG - Singapore 1.172
CN - Cina 816
IT - Italia 779
RU - Federazione Russa 645
BR - Brasile 496
VN - Vietnam 465
DE - Germania 205
HK - Hong Kong 194
BD - Bangladesh 176
GB - Regno Unito 147
CA - Canada 123
FR - Francia 109
IE - Irlanda 76
FI - Finlandia 70
IN - India 70
AR - Argentina 69
NL - Olanda 63
PL - Polonia 56
MX - Messico 54
TR - Turchia 47
ZA - Sudafrica 46
PK - Pakistan 41
ID - Indonesia 35
ES - Italia 34
UA - Ucraina 34
SE - Svezia 32
EC - Ecuador 30
IQ - Iraq 30
JP - Giappone 30
CO - Colombia 28
AT - Austria 23
LT - Lituania 20
IL - Israele 18
VE - Venezuela 18
SA - Arabia Saudita 17
UZ - Uzbekistan 15
AE - Emirati Arabi Uniti 12
BE - Belgio 12
MA - Marocco 10
CL - Cile 9
EG - Egitto 9
KE - Kenya 9
CH - Svizzera 8
JM - Giamaica 8
TN - Tunisia 8
JO - Giordania 7
MY - Malesia 7
OM - Oman 7
SI - Slovenia 6
KZ - Kazakistan 5
PE - Perù 5
PY - Paraguay 5
AU - Australia 4
AZ - Azerbaigian 4
DZ - Algeria 4
ET - Etiopia 4
HN - Honduras 4
NZ - Nuova Zelanda 4
PA - Panama 4
UY - Uruguay 4
AL - Albania 3
BO - Bolivia 3
DO - Repubblica Dominicana 3
KR - Corea 3
NP - Nepal 3
PH - Filippine 3
PT - Portogallo 3
SN - Senegal 3
TW - Taiwan 3
CR - Costa Rica 2
CY - Cipro 2
GP - Guadalupe 2
GR - Grecia 2
HR - Croazia 2
MD - Moldavia 2
NO - Norvegia 2
PR - Porto Rico 2
RO - Romania 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
BG - Bulgaria 1
BS - Bahamas 1
BW - Botswana 1
BZ - Belize 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
EE - Estonia 1
GD - Grenada 1
HU - Ungheria 1
IR - Iran 1
KN - Saint Kitts e Nevis 1
KW - Kuwait 1
KY - Cayman, isole 1
LB - Libano 1
MN - Mongolia 1
NG - Nigeria 1
RS - Serbia 1
Totale 10.860
Salva come PNG Salva come JPEG
Città #
Dallas 1.829
Singapore 661
Ashburn 402
San Jose 396
Beijing 274
Hong Kong 186
Ho Chi Minh City 169
Los Angeles 123
New York 116
Milan 105
Moscow 104
Hanoi 87
Dublin 76
Santa Clara 76
Rome 69
Council Bluffs 63
Chandler 61
Munich 58
São Paulo 56
Orem 52
Lauterbourg 49
The Dalles 47
Warsaw 45
Hefei 44
Buffalo 41
Montreal 41
Helsinki 37
Frankfurt am Main 36
Johannesburg 34
Brooklyn 32
Boardman 31
Chennai 31
San Mateo 30
Tokyo 28
Denver 27
London 27
Mexico City 26
Pisa 26
Houston 25
Ottawa 25
Amsterdam 23
Beauharnois 22
Bologna 22
Fairfield 22
Lappeenranta 22
Phoenix 22
Poplar 22
Seattle 22
Haiphong 21
Naples 21
Atlanta 20
Cambridge 20
Istanbul 19
Nuremberg 19
Boston 18
Chicago 18
Genoa 18
Da Nang 17
Portsmouth 17
Stockholm 16
Turin 16
West Jordan 16
Rio de Janeiro 15
San Francisco 15
Ankara 14
Brasília 14
Florence 14
Stevenage 14
Tashkent 14
Tel Aviv 14
Krefeld 13
Wilmington 13
Belo Horizonte 12
Biên Hòa 12
Querétaro 12
Bari 11
Guarulhos 11
Lahore 11
Lawrence 11
Manchester 11
Padua 11
Turku 11
Bad Bellingen 10
Brussels 10
Dong Ket 10
Medellín 10
Ninh Bình 10
Paris 10
Porto Alegre 10
Toronto 10
Washington 10
Buenos Aires 9
Jeddah 9
Nairobi 9
New Delhi 9
Shanghai 9
Shenzhen 9
Verona 9
Vienna 9
Columbus 8
Totale 6.501
Salva come PNG Salva come JPEG
Nome #
High prevalence of wild-type transthyretin cardiac amyloidosis in older adults with carpal tunnel syndrome, heart failure or increased left ventricular mass: The CAPTURE study 719
Impact of GFR Estimation Formulas on MECKI Score Performance and Prognostic Accuracy in Heart Failure: The MECKI-RENAL Study 469
Value of the HFA-PEFF and H2FPEF scores in patients with heart failure and preserved ejection fraction caused by cardiac amyloidosis 420
Gender and age normalization and ventilation efficiency during exercise in heart failure with reduced ejection fraction 309
Antithrombotic strategies in the catheterization laboratory for patients with acute coronary syndromes undergoing percutaneous coronary interventions: Insights from the EmploYEd antithrombotic therapies in patients with acute coronary Syndromes HOspitalized in Italian cardiac care units Registry 308
[Rationale and significance of the Italian Network for Cardiac Amyloidosis] 288
[Ten perspectives for research and innovation in cardiac amyloidosis] 283
A national survey on prevalence of possible echocardiographic red flags of amyloid cardiomyopathy in consecutive patients undergoing routine echocardiography: study design and patients characterization - the first insight from the AC-TIVE Study 263
Cardiovascular Death Risk in Recovered Mid-Range Ejection Fraction Heart Failure: Insights From Cardiopulmonary Exercise Test 254
Cardiac and neuromuscular features of patients with LMNA-related cardiomyopathy 248
[Transcatheter devices for chronic heart failure: state of the art] 246
Valvular heart disease in patients with cardiac amyloidosis 235
Echocardiographic Biventricular Coupling Index to Predict Precapillary Pulmonary Hypertension 233
Exploring the Prognostic Performance of MECKI Score in Heart Failure Patients with Non-Valvular Atrial Fibrillation Treated with Edoxaban 230
Sex differences in the prognostic role of achieving target doses of heart failure medications: Data from the Swedish Heart Failure Registry 227
Percorsi diagnostico-terapeutici assistenziali per i pazienti con amiloidosi cardiaca – Documento di consenso SIC/ANMCO. A cura della Rete Italiana dell’Amiloidosi Cardiaca (RIAC) 226
Early diagnosis, disease stage and prognosis in wild‐type transthyretin amyloid cardiomyopathy: The DIAMOND study 223
[Diagnostic-therapeutic care pathways for patients with cardiac amyloidosis - SIC/ANMCO Consensus document. Edited by the Italian Cardiac Amyloidosis Network (RIAC)] 220
Early diagnosis, disease stage and prognosis in wild-type transthyretin amyloid cardiomyopathy: The DIAMOND study 218
Roles of periodic breathing and isocapnic buffering period during exercise in heart failure 214
Diagnostic pathways to wild-type transthyretin amyloid cardiomyopathy: a multicentre network study 213
Exercise oscillatory ventilation and prognosis in heart failure patients with reduced and mid-range ejection fraction 213
Redefining the epidemiology of cardiac amyloidosis. A systematic review and meta-analysis of screening studies 209
Prognostic Role of Late Gadolinium Enhancement in Patients With Hypertrophic Cardiomyopathy and Low-to-Intermediate Sudden Cardiac Death Risk Score 209
Association between implantable defibrillator-detected sleep apnea and atrial fibrillation: The DASAP-HF study 208
Heart failure patients with improved ejection fraction: Insights from the MECKI score database 207
Critical Comparison of Documents From Scientific Societies on Cardiac Amyloidosis: JACC State-of-the-Art Review 204
Inferior Vena Cava Edge Tracking Echocardiography: A Promising Tool with Applications in Multiple Clinical Settings 200
Increased serum uric acid level predicts poor prognosis in mildly severe chronic heart failure with reduced ejection fraction. An analysis from the MECKI score research group 194
The chronic heart failure evolutions: Different fates and routes 190
Pressure-volume relationship by pharmacological stress cardiovascular magnetic resonance 188
Unmasking the prevalence of amyloid cardiomyopathy in the real world: results from Phase 2 of the AC-TIVE study, an Italian nationwide survey 185
Old and new equations for maximal heart rate prediction in patients with heart failure and reduced ejection fraction on beta-blockers treatment: results from the MECKI score data set 180
Phenotype and outcomes according to loop diuretic use in pulmonary arterial hypertension 177
Prevalence and clinical outcomes of isolated or combined moderate to severe mitral and tricuspid regurgitation in patients with cardiac amyloidosis 167
Left ventricular wall thickness and severity of cardiac disease in women and men with transthyretin amyloidosis 165
Myocarditis and pericarditis during COVID-19 pandemic: a study of the Italian Society of Cardiology 163
Outcome and Disease Progression in NYHA Functional Class I and II Patients With Wild-Type Transthyretin Cardiomyopathy Treated With Tafamidis 162
Change in prevalence of ATTR variants in Italy: results from a national survey 160
Cardiac amyloidosis: when to suspect and how to confirm 151
Global Right Heart Assessment with Speckle-Tracking Imaging Improves the Risk Prediction of a Validated Scoring System in Pulmonary Arterial Hypertension 146
Right ventricular to pulmonary artery coupling and outcome in patients with cardiac amyloidosis 136
Tafamidis in the Treatment of ATTR-related Cardiomyopathy 100
Cardiac Resynchronization Therapy, Remodeling, and Outcome in Patients With Amyloid Transthyretin Cardiomyopathy 91
Clinical phenotype and prognosis of real-world patients with wild-type transthyretin amyloid cardiomyopathy treated with tafamidis 72
Contemporary medical therapy for heart failure across the ejection fraction spectrum: The OPTIPHARM-HF registry 67
Impact of glomerular filtration rate estimation formulas on MECKI score performance and prognostic accuracy in heart failure: The MECKI-RENAL study 64
Changes in CMR-derived ventricular strain, fibrosis progression and outcomes in hypertrophic cardiomyopathy 60
Impact of glomerular filtration rate estimation formulas on MECKI score performance and prognostic accuracy in heart failure: the MECKI-RENAL study 57
Light chain amyloidosis: multidisciplinary management and innovative therapeutic strategies. SIC/ANMCO Consensus document of the Italian Cardiac Amyloidosis Network (RIAC) 53
Analysis of Calcium Scores in Severe Aortic Stenosis Patients With and Without Cardiac Amyloidosis 53
Current Standards and Perspectives in Proteomics for Cardiac Amyloidosis 49
Real-world candidacy to mavacamten in a contemporary hypertrophic obstructive cardiomyopathy population 49
OPTImal PHARMacological therapy for patients with heart failure: Rationale and design of the OPTIPHARM-HF registry 48
Natural History of Patients With Histologically Proven Acute Eosinophilic Myocarditis 47
Analysis of Calcium Scores in Severe Aortic Stenosis Patients With and Without Cardiac Amyloidosis: The CAUSATIVE Study 46
ECG/echo indexes in the diagnostic approach to amyloid cardiomyopathy: A head-to-head comparison from the AC-TIVE study 45
Magnetic Resonance Imaging Characterization and Clinical Outcomes of Dilated and Arrhythmogenic Left Ventricular Cardiomyopathies 43
Electrocardiographic abnormalities in patients with cardiomyopathies 35
SGLT2 Inhibitor Therapy in Patients With Transthyretin Amyloid Cardiomyopathy 34
Late gadolinium enhancement dispersion for predicting malignant arrhythmic events in patient with non-ischaemic dilated cardiomyopathy 30
Cascade genetic screening in families with hereditary transthyretin amyloidosis: diagnostic and prognostic impact 26
null 26
High Prevalence of Wild-Type Transthyretin Cardiac Amyloidosis in Older Adults with Carpal Tunnel Syndrome, Heart Failure or Increased Left Ventricular Mass: The CAPTURE Study 14
Diagnostic Role of Wall Thickness Heterogeneity in Hypertrophic Cardiomyopathy and in Carriers of Sarcomeric Gene Mutations 3
Totale 10.972
Salva come PNG Salva come JPEG
Categoria #
all - tutte 47.055
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.055
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202118 0 0 0 0 0 0 0 0 0 0 0 18
2021/2022174 19 25 2 19 0 6 19 25 10 28 7 14
2022/2023204 12 21 3 15 22 23 5 23 52 1 17 10
2023/2024332 10 7 39 23 5 16 13 27 43 33 33 83
2024/20251.825 31 81 137 52 112 90 243 397 160 70 265 187
2025/20268.336 311 944 1.798 876 686 503 715 488 709 585 594 127
Totale 10.972